The etiology, biology, and evolving pathology of premenstrual syndromes

Psychoneuroendocrinology

Volumn 28, Issue SUPPL. 3, 2003, Pages 55-99

  Halbreich, Uriel ^a  

^a UNIVERSITY AT BUFFALO   (United States)

Author keywords

Estrogen; Menstrually related disorders; Pathophysiology; Premenstrual Dysphoric Disorder (PMDD); Premenstrual syndrome (PMS); Progesterone

Indexed keywords

4 AMINOBUTYRIC ACID; ALPHA ADRENERGIC RECEPTOR STIMULATING AGENT; ALPRAZOLAM; AMFEBUTAMONE; BENZODIAZEPINE; BROMOCRIPTINE; CALCIUM CARBONATE; CHOLECYSTOKININ; CITALOPRAM; CLOMIPRAMINE; DANAZOL; ELTANOLONE; ESTRADIOL; FLUOXETINE; GONADORELIN AGONIST; LEVOTHYROXINE; LITHIUM; MAPROTILINE; MIFEPRISTONE; ORAL CONTRACEPTIVE AGENT; PAROXETINE; PRIMROSE OIL; PROGESTERONE; PROGESTERONE DERIVATIVE; SEROTONIN; SEROTONIN AGONIST; SERTRALINE; SPIRONOLACTONE; VENLAFAXINE; AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS; CORTICOTROPIN RELEASING FACTOR; ESTROGEN; SEX HORMONE;

ANXIETY; ARTICLE; BEHAVIOR THERAPY; COGNITIVE THERAPY; DEPRESSION; DIFFERENTIAL DIAGNOSIS; DISEASE ASSOCIATION; DRUG EFFICACY; ENVIRONMENTAL CHANGE; EPILEPSY; EVIDENCE BASED MEDICINE; EXERCISE; GENETIC ASSOCIATION; GENETIC CORRELATION; GENETIC DISORDER; GENETIC SUSCEPTIBILITY; HORMONAL REGULATION; HORMONE METABOLISM; HUMAN; IRRITABILITY; LIFE CYCLE; LUTEAL PHASE; MENSTRUAL CYCLE; MIGRAINE; NEUROTRANSMISSION; NUTRITION; OVARIECTOMY; PATHOPHYSIOLOGY; PREMENSTRUAL DYSPHORIC DISORDER; PREMENSTRUAL SYNDROME; PRIORITY JOURNAL; PROGESTERONE METABOLISM; RELAXATION TRAINING; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SELF CARE; SOCIAL SUPPORT; SYMPTOMATOLOGY; ENVIRONMENT; FEMALE; GENETICS; LIFE EVENT; PATHOLOGY; REVIEW;

CORTICOTROPIN-RELEASING HORMONE; DEPRESSION; ENVIRONMENT; ESTROGENS; EVIDENCE-BASED MEDICINE; FEMALE; GONADAL HORMONES; HUMANS; LIFE CHANGE EVENTS; MENSTRUAL CYCLE; NEUROTRANSMITTER AGENTS; PREMENSTRUAL SYNDROME; PROGESTERONE;

EID: 0038246106     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4530(03)00097-0     Document Type: Article

References (270)

1. Abramowitz, E.S., Baker, A.H., Fleiscler, S., 1982. Onset of depressive psychiatric crisis and the menstrual cycle. Am J Psychiatry 139, 475-478.
2. Agarwal, A.K., Shah, A., 1997. Menstrual-linked asthma. J Asthma 34, 539-545.
3. Akiskal, H.S., McKinney, W.T.J., 1973. Depressive disorders: toward a unified hypothesis. Science 182, 20-29.
4. Akiskal, H.S., McKinney, W.T.J., 1975. Overview of recent research in depression: integration of ten conceptual models into a comprehensive clinical frame. Arch Gen Psychiatry 32, 285-305.
5. Altshuler, L.L., Cohen, L.S., Moline, M.L., Kahn, D.A., Carpenter, D., Docherty, J.P., 2001. The expert consensus guideline series. Treatment of depression in women. Postgrad Med, 1-107.
6. American College of Obstetricians and Gynecologists (ACOG) 1989. Premenstrual Syndrome: Committee Opinion No. 66. ACOG, Washington, DC.
7. American College of Obstetricians and Gynecologists (ACOG) 2000. Premenstrual Syndrome, Vol. 15. ACOG, Washington, DC.
8. American Psychiatric Association 1994. Diagnostic and Statistical Manual of Mental Disorders, third ed. American Psychiatric Press, Inc., Washington, DC.
9. Andersch, B., Wenderstam, C., Hahn, L., et al. 1986. Prevalence of premenstrual symptoms in a Swedish urban population. J Psychosom Obstet & Gynaecol 5, 39.
10. Andrews, G., 1981. A prospective study of life events and psychological symptoms. Psychol Med 11, 795-901.
11. Angst, J., Sellaro, R., Merikangas, K.R., Endicott, J., 2001. The epidemiology of preimenstrual psychological symptoms. Acta Psychiatrica Scandinavica 104, 110-116.
12. Antonucci, T.C., Jackson, J.S., 1990. The role of reciprocity in social support. In: Sarason, B.R., Sarason, I.G., Pierce, G.R. (Eds.), Social Support: An Interactive View. John Wiley and Sons, New York, pp. 173-198.
13. Ashby, C.R. Jr., Carr, L.A., Cook, C.L., Steptoe, M.M., Franks, D.D., 1988. Alteration of platelet serotonergic mechanisms and monoamine oxidase activity in premenstrual syndrome. Biol Psychiatry 24, 225-233.
14. Backstrom, T., 1976. Epileptic seizures in women related to plasma estrogen and progesterone during the menstrual cycle. Acta Neurol Scand 54, 321-347.
15. Backstrom, T., 1995. Symptoms related to the menopause and sex steroid treatments. Ciba Foundation Symposium 191, 171-186.
16. Backstrom, T., Landgren, S., Zetterland, B., 1984. Effects of ovarian steroid hormones on brain excitability and their relation to epilepsy seizure, variation during the menstrual cycle. In: Porter, R.J., Mattson, R.H., Ward, A.A.J. (Eds.), Advances in Epileptology, Vol. 15. Raven Press, New York, pp. 269-277.
17. Backstrom, T., Sanders, D., Leask, R., Davidson, D., Warner, P., Bancroft, J., 1983. Mood, sexuality, hormones, and the menstrual cycle. II. Hormone levels and their relationship to the premenstrual syndrome. Psychosom Med 45, 503-507.
18. Bancroft, J., Cook, A., Davidson, D., Bennie, J., Goodwin, G., 1991. Blunting of neuroendocrine responses to infusion of L-tryptophan in women with preimenstrual mood change. Psychological Medicine 21, 305-312.
19. Bancroft, J., Rennie, D., Warner, P., 1994. Vulnerability to preimenstrual mood change: The relevance of a past history of depressive disorder. Psychosom Med 56, 225-231.
20. Barnhart, K.T., Freeman, E.W., Sondheimer, S.J., 1995. A clinician's guide to the premenstrual syndrome. Med Clin North Am 79, 1457-1472.
21. Bebbington, P., Hurry, J., Tennant, C., 1981a. Epidemiology of mental disorders in Camberwell. Psychological Medicine 11, 576-579.
22. Bebbington, P.E., Brugha, T.S., MacCarthy, B., Potter, J., Sturt, E., Wykes, T., Katz, R., McGuffin, P., 1988. The Camberwell collaborative depression study, I: depressed probands: adversity and the form of depression. Br J Psychiatry 152, 754-765.
23. Bebbington, P.E., Tennant, C., Hurry, J., 1981b. Adversity and the nature of psychiatric disorder in the community. Journal of Affective Disorders 3, 345-366.
24. Bergeman, C.S., Plomin, R., Pedersen, N.L., McClearn, G.E., Nesselroade, J.R., 1990. Genetic and environmental influences on social support: the Swedish Adoption Twin Study of Aging (SATSA). J Gerontol 45, 101-106.
25. Bhatia, S.C., Bhatia, S.K., 1999. Depression in women: diagnostic and treatment considerations. Am Fam Physician 60 (225-234), 239-240.
26. Bicikova, M., Dibbelt, L., Hill, M., Hampl, R., Starka, L., 1998. Allopregnanolone in women with premenstrual syndrome. Hormone & Metabolic Research 30, 227-230.
27. Birge, S., 1997. The role of estrogen in the treatment of Alzheimer's disease. Neurology 48 (Suppl. 7), S36-S41.
28. Bloch, M., Schmidt, P.J., T.-P., S., Tobin, M.B., Rubinow, D.R., 1996. ACTH and beta-endorphin over the menstrual cycle in women with PMS and controls. Biol Psychiatry 39, 648-649.
29. Blumer, D., 1997. Antidepressant and double antidepressant treatment for the affective disorder of epilepsy. Journal of Clinical Psychiatry 58, 3-11.
30. Blumer, D., Herzog, A., Himmelhoch, J., Salgueiro, C., Ling, F., 1998a. To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy. J Affective Disorders 48, 215-225.
31. Blumer, D., Herzog, A.G., Himmelhoch, J., Salgueiro, C.A., Ling, F.W., 1998b. To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy. Journal of Affective Disorders 48, 215-225.
32. Borenstein, J.E., Brown, C.S., Chuong, C.J., Dickerson, V., Endicott, J., Freeman, E.W., Futterman, L.A., Greenberger, P., Halbreich, U., Keye, W.R., et al. 2003. An evidence-based approach to the management of premenstrual syndrome: Report of findings of a modified Delphi panel. Lynx Health Inc, Los Angeles.
33. Boyle, C.A., 1999. Management of menstrual migraine. Neurology 53, S14-S18.
34. Bradwejn, J., Koszycki, D., Shriqui, C., 1991. Enhanced sensitivity to cholecystokinin tetrapeptide in panic disorder. Clinical and behavioral findings. Arch Gen Psychiatry 48, 603-610.
35. Brawman-Mintzer, O., Lydiard, R.B., 1997. Biological basis of generalized anxiety disorder. J Clin Psychiatry 58, 16-25 Discussion 26.
36. Breaux, C., Hartlage, S., Gehlert, S., 2000. Relationships of premenstrual dysphoric disorder to major depression and anxiety disorders: a re-examination. J Psychosom Obstet Gynecol 21, 17-24.
37. Breslau, N., Davis, G.C., Andreski, P., Peterson, E., 1991. Traumatic events and posttraumatic stress disorder in an urban population of young adults. Arch Gen Psychiatry 48, 216-222.
38. Britton, K.T., Koob, G.F., 1998. Neuropharmacology. Premenstrual steroids? Nature 392, 869-870.
39. Brockington, I.F., Kelly, A., Hall, P., 1988a. Premenstrual relapse puerperal psychosis. J Affect Disord 14, 287-292.
40. Brockington, I.F., Margison, F.R., Schofield, E.M., Knight, R.J.E., 1988b. The clinical picture of the depressed form of puerperal psychosis. Journal of Affective Disorders 15, 29-37.
41. Brown, G.W., Harris, T., 1978. Social origins of depression: a study of psychiatric disorder in women. Free Press, New York.
42. Brown, G.W., Harris, T.O., 1989. Life events and illness. Guilford Press, New York.
43. Brzezinski, A.A., Wurtman, J.J., Wurtman, R.J., Gleason, R., Greenfield, J., Nader, T., 1990. d-Fenfluramine suppresses the increased calorie and carbohydrate intakes and improves the mood of women with premenstrual depression. Obstet Gynecol 76, 296-301.
44. Campbell, E.M., Peterkin, D., O'Grady, K., Sanson-Fisher, R., 1997. Premenstrual symptoms in general practice patients. Prevalence and treatment. Journal of Reproductive Medicine 42, 637-646.
45. Case, A.M., Reid, R.L., 1998. Effects of the menstrual cycle on medical disorders. Arch Intern Med 158, 1405-1412.
46. Casper, R.F., Patel-Christopher, A., Powell, A., 1989. Thyrotropin and prolactin responses to thyrotropin-releasing hormone in premenstrual syndrome. J Clin Endocrinol Metab 68, 608-612.
47. Chakravorty, S.G., Halbreich, U., 1997. The influence of estrogen on monoamine oxidase activity. Psychopharmacol Bull 33, 229-233.
48. Chrousos, G.P., Torpy, D.J., Gold, P.W., 1998. Interactions between the hypothalamic-pituitary-adrenal axis and the female reproductive system: Clinical implications. Ann Intern Med 129, 229-240.
49. Chuong, C.J., Coulam, C.B., Kao, P.C., Bergstralh, E.J., Go, V.L., 1985. Neuropeptide levels in premenstrual syndrome. Fertil Steril 44, 760-765.
50. Chuong, C.J., Hsi, B.P., Gibbons, W.E., 1994. Periovulatory beta-endorphin levels in premenstrual syndrome. Obstet Gynecol 83, 755-760.
51. Cohen, L., Miner, C., Brown, E., Freeman, E., Halbreich, U., Sundell, K., McCray, S., 2002. Premenstrual daily fluoxetine for premenstrual dysphoric disorder: a placebo-controlled, clinical trial using computerized diaries. Obstet Gynecol 100, 435-444.
52. Condon, J.T., 1993. The premenstrual syndrome: a twin study. Br J Psychiatry 162, 481-486.
53. Coppen, A., 1965. The prevalence of menstrual disorders in psychiatric patients. Br J Psychiatry 111, 155-167.
54. Coppen, A., Kessel, N., 1963. Menstruation and personality. British Journal of Psychiatry 109, 711-721.
55. Cowley, D.S., Roy-Byrne, P., Hommer, D.W., Greenblatt, D.J., Nemeroff, C., Ritchie, J., 1991. Benzodiazepine sensitivity in anxiety disorders. Biol Psychiatry 29, 57A.
56. Cutler, S.E., Nolen-Hocksema, S., 1991. Accounting for sex differences in depression through female victimization: childhood sexual abuse. Sex Roles 24, 425-438.
57. Dahr, V., Murphy, B.E.P., 1990. Double-blind randomized crossover trial of luteal phase estrogens (Premarin). Psychoneuroendrocrinology 15, 489-493.
58. Dalton, K., Dalton, M.E., Guthrie, K., 1987. Incidence of the premenstrual syndrome in twins. BMJ 295, 1027-1028.
59. De Ronchi, D., Muro, A., Marziani, A., Rucci, P., 2000. Personality disorders and depressive symptoms in late luteal phase dysphoric disorder. Psychother Psychosom 69, 27-34.
60. Dickerson, V., Yonkers, K., 2003. Monograph: An evidence-based approach to the diagnosis and management of premenstrual syndrome. Beverly Hills CA: Zynx Health, Cedar Sinai Health System.
61. Dickinson, S.L., Curzon, G., 1986. 5-Hydroxytryptamine-mediated behavior in male and female rats. Neuropharmacology 25, 771-776.
62. d'Orban, P.T., Dalton, J., 1980. Violent crime and the menstrual cycle. Psychol Med 10, 353-359.
63. Dubovsky, S.L., Thomas, M., 1995. Serotonergic mechanisms and current and future psychiatric practice. J Clin Psychiatry 56, 38-48.
64. Eaton, W., 1978. Life events, social supports and psychiatric symptoms: a re-analysis of New Haven data. J Health Soc Behav 19, 230-234.
65. Endicott, J., Amsterdam, J., Eriksson, E., Frank, E., Freeman, E., Hirschfeld, R., Ling, F., Parry, B., Pearlstein, T., Rosenbaum, J., et al. 1999. Is premenstrual dysphoric disorder a distinct clinical entity? Journal of Womens Health & Gender-Based Medicine 8, 663-679.
66. Endicott, J., Halbreich, U., 1988. Clinical significance of premenstrual dysphoric changes. J Clin Psychiatry 49, 486-489.
67. Endicott, J., Nee, J., Cohen, J., Halbreich, U., 1986. Premenstrual changes: Patterns and correlates of daily ratings. J Affect Disord 10, 127-135.
68. Epperson, C.N., Haga, K., Mason, G.F., Sellers, E., Gueorguieva, R., Zhang, W., Weiss, E., Rothman, D.L., Krystal, J.H., 2002. Cortical gamma-aminobutyric acid levels across the menstrual cycle in healthy women and those with premenstrual dysphoric disorder: A proton magnetic resonance spectroscopy study. Arch Gen Psychiatry 59, 851-858.
69. Eriksson, E., Hedberg, M.A., Andersch, B., Sundblad, C., 1995. The serotonin reuptake inhibitor paroxetine is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome. Neuropsychopharmacology 12, 167-176.
70. Facchinetti, F., Fioroni, L., Martignoni, E., Sances, G., Costa, A., Genazzani, A.R., 1994. Changes of opioid modulation of the hypothalamo- pituitary-adrenal axis in patients with severe premenstrual syndrome. Psychosomatic Medicine 56, 418-422.
71. Facchinetti, F., Genazzani, A.D., Martignoni, E., Fioroni, L., Nappi, G., Genazzani, A.R., 1993. Neuroendocrine changes in luteal function in patients with premenstrual syndrome. Journal of Clinical Endocrinology & Metabolism 76, 1123-1127.
72. Facchinetti, F., Genazzani, A.D., Martignoni, E., Fioroni, L., Sances, G., Genazzani, A.R., 1990. Neuroendocrine correlates of premenstrual syndrome: changes in the pulsatile pattern of plasma LH. Psychoneuroendocrinology 15, 269-277.
73. Facchinetti, F., Martignoni, E., Petraglia, F., Sances, M.G., Nappi, G., Genazzani, A.R., 1987. Premenstrual fall of plasma beta-endorphin in patients with premenstrual syndrome. Fertility & Sterility 47, 570-573.
74. Facchinetti, F., Martignoni, E., Sola, D., Petraglia, F., Nappi, G., Genazzani, A.R., 1988. Transient failure of central opioid tonus and premenstrual symptoms. Journal of Reproductive Medicine 33, 633-638.
75. Facchinetti, F., Romano, G., Fava, M., Genazzani, A.R., 1992. Lactate infusion induces panic attacks in patients with premenstrual syndrome. Psychosomatic Medicine 54, 288-296.
76. Fava, M., 1992. Comorbid anxiety and depression among patients with late luteal phase dysphoric disorder. J Anxiety Disord 6, 325-335.
77. Fergusson, D.M., Horwood, L.J., 1984. Life events and depression in women: a structural equation model. Psychol Med 14, 881-889.
78. Fergusson, D.M., Horwood, L.J., 1987. Vulnerability to life event exposure. Psychol Med 17, 739-749.
79. Foresti, G., Ferraro, M., Reithaar, P., 1981. Premenstrual syndrome and personality traits: a study on 110 pregnant patients. Psychotherapy and Psychosomatics 36, 37-41.
80. Freeman, E.W., 1997. Premenstrual syndrome: current perspectives on treatment and etiology. Current Opinion in Obstetrics & Gynecology 9, 147-153.
81. Freeman, E.W., Rickels, K., Sondheimer, S.J., Polansky, M., 1999. Differential response to antidepressants in women with premenstrual syndrome/premenstrual dysphoric disorder: a randomized controlled trial. Arch Gen Psychiatry 56, 932-939.
82. Freeman, E.W., Rickels, K., Sondheimer, S.J., Polansky, M.P., 1995. A double-blind trial of oral progesterone, alprazolam, and placebo in treatment of severe premenstrual syndrome. JAMA 274, 51-57.
83. Freeman, E.W., Sondheimer, S.J., Rickels, K., Albert, J., 1993. Gonadotropin-releasing hormone agonist in treatment of premenstrual symptoms with and without comorbidity of depression: a pilot study. J Clin Psychiatry 54, 192-195.
84. Friedman, R.C., Hurt, S.W., Charkin, J., 1982. Sexual histories and premenstrual affective syndrome in psychiatric inpatients. Am J Psychiatry 139, 1484-1486.
85. Fuhrmann, U., Krattenmacher, R., Slater, E.P., Fritzemeier, K.H., 1996. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential. Contraception 54, 243-251.
86. Garcia-Sevilla, J.A., Zis, A.P., Hollingsworth, P.J., Greden, J.F., Smith, C.B., 1981. Platelet alpha 2-adrenergic receptors in major depressive disorder. Binding of tritiated clonidine before and after tricyclic antidepressant drug treatment. Arch Gen Psychiatry 38, 1327-1333.
87. Giannini, A.J., Martin, D.M., Turner, C.E., 1990. Beta-endorphin decline in late luteal phase dysphoric disorder. Int J Psychiatry Med 20, 279-284.
88. Gitlin, M.J., Pasnau, R.O., 1989. Psychiatric syndromes linked to reproductive function in women: A review of current knowledge. Am J Psychiatry 146, 1413-1422.
89. Gladis, M.M., Walsh, B.T., 1987. Premenstrual exacerbation of binge eating in bulimia. Psychiatry 144, 1592-1595.
90. Glick, H., Endicott, J., Nee, J., 1993. Premenstrual charges: are they familial? Acta Psychiatr Scand 88, 149-155.
91. Goldstein, S., Halbreich, U., Asnis, G., Endicott, J., Alvir, J., 1987. The hypothalamic-pituitary-adrenal system in panic disorder. Am J Psychiatry 144, 1320-13203.
92. Gorman, J.M., Kent, J., Martinez, J., Browne, S., Coplan, J., Papp, L.A., 2001. Physiological changes during carbon dioxide inhalation in patients with panic disorder, major depression, and premenstrual dysphoric disorder: evidence for a central fear mechanism. Arch Gen Psychiatry 58, 125-131.
93. Gottfredson, M.R., 1981. On the etiology of criminal victimization. J Criminal Law 72, 714-726.
94. Graze, K.K., Nee, J., Endicott, J., 1990. Premenstrual depression predicts future major depressive disorder. Acta Psychiatr Scand 81, 201-205.
95. Griffin, L.D., Mellon, S.H., 1999. Selective serotonin reuptake inhibitors directly alter activity of neurosteroidogenic enzymes. Proc Natl Acad Sci USA 96, 13512-13517.
96. Gurguis, G.N., Yonkers, K.A., Phan, S.P., Blakeley, J.E., Williams, A., Rush, A.J., 1998a. Adrenergic receptors in premenstrual dysphoric disorder: I. Platelet alpha 2 receptors: Gi protein coupling, phase of menstrual cycle, and prediction of luteal phase symptom severity. Biol Psychiatry 44, 600-609.
97. Gurguis, G.N.M., Yonkers, K.A., Blakeley, J.E., Phan, S.P., Rush, J., 1998b. Adrenergic receptors in premenstrual dysphoric disorder: II. Neutrophil 2-adrenergic receptors: G3 protein coupling, phase of menstrual cycle and prediction of luteal phase symptom severity. Psychiatry Res 79, 31-42.
98. Halbreich, U., 1990. Treatment of premenstrual syndromes with progesterone antagonists (e.g., RU-486): political and methodological issues. Psychiatry 53, 407-409.
99. Halbreich, U., 1993. Menstrually related changes and disorders: conceptualization and diagnostic considerations. Neuropsychopharmacology 9, 25-29.
100. Halbreich, U., 1997a. Menstrually related disorders - towards interdisciplinary international diagnostic criteria. Cephalalgia 17 (Suppl. 20), 1-4.
101. Halbreich, U., 1997b. Premenstrual dysphoric disorders: a diversified cluster of vulnerability traits to depression. Acta Psychiatr Scand 95, 169-176.
102. Halbreich, U., 1997c. Role of estrogen in postmenopausal depression. Neurology 48, S16-S19.
103. Halbreich, U., 1999. Premenstrual syndromes: closing the 20th century chapters. Curr Opin Obstet Gynecol 11, 265-270.
104. Halbreich, U., 2000. Gonadal hormones, reproductive age, and women with depression. Arch Gen Psychiatry 57, 1163-1164.
105. Halbreich U., Effects of the Steroid Antagonist Mifepristone on Premenstrual Symptoms When Given at the Beginning and at the Mid-Luteal Phase of the Menstrual Cycle (submitted for publication).
106. Halbreich, U., Alt, I.H., Paul, L., 1988a. Premenstrual changes. Impaired hormonal homeostasis. Neurol Clin 6, 173-194.
107. Halbreich, U., Alt, I.H., Paul, L., 1988b. Premenstrual changes. Impaired hormonal homeostasis. Endocrinol Metab Clin North Am 17, 173-194.
108. Halbreich, U., Bancroft, J., Dennerstein, L., Endicott, J., Faccinetti, F., Genazzani, A., Morse, C., Parry, B., Rubinow, D., Reid, R., 1993a. Menstrually Related Disorders: points of consensus, debate, and disagreement. Neuropsychopharmacology 9 (13-15), 17-29 discussion.
109. Halbreich, U., Bergeron, R., Yonkers, K.A., Freeman, E., Stout, A.L., Cohen, L., 2002. Efficacy of intermittent, luteal phase sertraline treatment of premenstrual dysphoric disorder. Obstet Gynecol 100, 1219-1229.
110. Halbreich U., Borenstein J., Pearlstein T., Kahn L., 2003. The prevalence, impairment, impact, and burden of Premenstrual Dysphoric Disorder (PMS/PMDD). Psychoneuroendocrinology 2853, 1-23.
111. Halbreich, U., Endicott, J., 1981. Possible involvement of endorphin withdrawal or imbalance in specific premenstrual syndromes and postpartum depression. Med Hypotheses 7, 1045-1058.
112. Halbreich, U., Endicott, J., 1982. Future directions in the study of premenstrual changes. Psychopharm Bull 18, 121-123.
113. Halbreich, U., Endicott, J., 1985. Relationship of dysphoric premenstrual changes to depressive disorders. Acta Psychiatr Scand 71, 331-338.
114. Halbreich, U., Endicott, J., Goldstein, S., Nee, J., 1986. Premenstrual changes and changes in gonadal hormones. Acta Psychiatr Scand 74, 576-586.
115. Halbreich, U., Endicott, J., Schacht, S., Nee, J., 1982. The diversity of premenstrual changes as reflected in the Premenstrual Assessment Form. Acta Psychiatr Scand 65, 46-65.
116. Halbreich, U., Kas, D., 1977. Variations in the Taylor MAS of women with premenstrual syndrome. J Psychosom Res 21, 391-393.
117. Halbreich, U., Petty, F., Yonkers, K., Kramer, G.L., Rush, A.J., Bibi, K.W., 1996. Low plasma gamma-aminobutyric acid levels during the late luteal phase of women with premenstrual dysphoric disorder. Am J Psychiatry 153, 718-720.
118. Halbreich, U., Piletz, J.E., Carson, S., Halaris, A., Rojansky, N., 1993b. Increased imidazoline and alpha 2 adrenergic binding in platelets of women with dysphoric premenstrual syndromes. Biol Psychiatry 34, 676-686.
119. Halbreich, U., Rojansky, N., Palter, S., 1991. Elimination of ovulation and menstrual cyclicity (with danazol) improves dysphoric premenstrual syndromes. Fertil Steril 56, 1066-1069.
120. Halbreich, U., Rojansky, N., Palter, S., Tworek, H., Hissin, P., Wang, K., 1995. Estrogen augments serotonergic activity in postmenopausal women. Biol Psychiatry 37, 434-441.
121. Hamilton, J.A., Parry, B., Alagna, S., Blumenthal, S., Herz, E., 1984. Premenstrual mood changes: a guide to evaluation and treatment. Psychiatric Annals 14, 426-435.
122. Hammarback, S., Backstrom, T., Holst, J., von Schoultz, B., Lyrenas, S., 1985. Cyclical mood changes as in the premenstrual tension syndrome during sequential estrogen-progestagen postmenopausal replacement therapy. Acta Obstetricia et Gynecologica Scandinavica 64, 393-397.
123. Hammarback, S., Ekholm, U.B., Backstrom, T., 1991. Spontaneous anovulation causing disappearance of cyclical symptoms in women with the premenstrual syndrome. Acta Endocrinol (Copenh) 125, 132-137.
124. Harlow, B.L., Cohen, L.S., Otto, M.W., Spiegelman, D., Cramer, D.W., 1999. Prevalence and predictors of depressive symptoms in older premenopausal women: the Harvard Study of Moods and Cycles. Arch Gen Psychiatry 56, 418-424.
125. Harrison, W.M., Endicott, J., Nee, J., 1990. Treatment of premenstrual dysphoria with alprazolam. A controlled study. Arch Gen Psychiatry 47, 270-275.
126. Harrison, W.M., Endicott, J., Nee, J., Glick, H., Rabkin, J.G., 1989a. Characteristics of women seeking treatment for premenstrual syndrome. Psychosomatics 30, 405-411.
127. Harrison, W.M., Endicott, J., Rabkin, J.G., Nee, J., 1984. Treatment of premenstrual dysphoric changes: clinical outcome and methodological implications. Psychopharmacol Bull 20, 118-122.
128. Harrison, W.M., Sandberg, D., Gorman, J.M., Fyer, M., Nee, J., Uy, J., Endicott, J., 1989b. Provocation of panic with carbon dioxide inhalation in patients with premenstrual dysphoria. Psychiatry Res 27, 183-192.
129. Hatotani, N., Nishikubo, M., Iitayama, I., 1979. Periodic psychosis in the female and the reproductive process. In: Zichella, L., Pancheri, P. (Eds.), Psychoneuroendocrinology in reproduction. Elsevier North Holland, New York, pp. 55-68.
130. Hendrick, V., Altshuler, L.L., 1998. Recurrent mood shifts of premenstrual dysphoric disorder can be mistaken for rapid-cycling bipolar II disorder [letter]. Journal of Clinical Psychiatry 59, 479-480.
131. Herzog, A., 1989. Preimenopausal depression: possible role of anomalous brain substrates. Brain Dysfunction 2, 146-154.
132. Himmelhoch, J.M., 1984. Major mood disorders related to epileptic changes. In: Blumer, D. (Ed.), Psychiatric Aspects of Epilepsy. American Psychiatric Press, Washington DC, pp. 271-294.
133. Hirschfeld, R.M.A., Klerman, G.L., Clayton, P.J., Keller, M.B., 1983. Personality and depression: empirical findings. Arch Gen Psychiatry 40, 993-998.
134. Holmes, S.J., Robins, L.N., 1988. The role of parental disciplinary practices in the development of depression and alcoholism. Psychiatry 51, 24-36.
135. Holzbauer, M., Youdim, M.B., 1973. The oestrous cycle and monoamine oxidase activity. Br J Pharmacol 48, 600-608.
136. Hylan, T.R., Sundell, K., Judge, R., 1999. The impact of premenstrual symptomatology on functioning and treatment-seeking behavior: experience from the United States, United Kingdom and France. Journal of Womens Health & Gender-Based Medicine 8, 1043-1052.
137. Johnson, S.R., McChesney, C., Bean, J.A., 1988. Epidemiology of premenstrual symptoms in a nonclinical sample. I. Prevalence, natural history and help-seeking behavior. J Reprod Med 33, 340-346.
138. Kahn, L.S., Halbreich, U., 2001. Oral contraceptives and mood. Expert Opin Pharmacother 2, 1367-1382.
139. Kantero, R.L., Widholm, O., 1971. Correlations of menstrual traits between adolescent girls and their mothers. Acta Obstet Gynaecol Scand Suppl 14, 30-36.
140. Kashiwagi, T., McClure, J.N., Wetzel, R., 1976. Premenstrual affective syndrome and psychiatric disorder. Dis Nerv Syst 37, 116-119.
141. Katz, R.J., Landau, P.S., Lott, M., Bystritsky, A., Diamond, B., Hoehn-Saric, R., Rosenthal, M., Weise, C., 1993. Serotonergic (5-HT2) mediation of anxiety-therapeutic effects of serazepine in generalized anxiety disorder. Biol Psychiatry 34, 41-44.
142. Keane, T.M., Wolfe, J., 1990. Comorbidity in post-traumatic stress disorder: an analysis of community and clinical studies. J Applied Social Psychol 20, 1777-1788.
143. Keenan, P.A., Stern, R.A., Janowsky, D.S., Pendersen, C.A., 1992. Psychological aspects of premenstrual syndrome. I. Cognition and memory. Psychoneuroendocrinology 17, 179-187.
144. Kendler, K.S., 1997. Social support: a genetic-epidemiologic analysis. Am J Psychiatry 154, 1398-1404.
145. Kendler, K.S., Karkowski, L.M., Corey, L.A., Neale, M.C., 1998. Longitudinal population-based twin study of retrospectively reported premenstrual symptoms and lifetime major depression. Am J Psychiatry 155, 1234-1240.
146. Kendler, K.S., Kessler, R.C., Neale, M.C., Heath, A.C., Eaves, L.J., 1993a. The prediction of major depression in women: toward an integrated etiologic model. Am J Psychiatry 150, 1139-1148.
147. Kendler, K.S., Kessler, R.C., Walters, E.E., MacLean, C., Neale, M.C., Heath, A.C., Eaves, L.J., 1995a. Stressful life events, genetic liability, and onset of an episode of major depression in women. Am J Psychiatry 152, 833-842.
148. Kendler, K.S., Neale, M., Kessler, R., Heath, A., Eaves, L., 1993b. A twin study of recent life events and difficulties. Arch Gen Psychiatry 50, 789-796.
149. Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1992a. Generalized anxiety disorder in women. A population-based twin study. Arch Gen Psychiatry 49, 267-272.
150. Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1992b. Major depression and generalized anxiety disorder. Same genes, (partly) different environments? Arch Gen Psychiatry 49, 716-722.
151. Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1992c. A population-based twin study of major depression in women. The impact of varying definitions of illness. Arch Gen Psychiatry 49, 257-266.
152. Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1993c. A longitudinal twin study of 1-year prevalence of major depression in women. Arch Gen Psychiatry 50, 843-852.
153. Kendler, K.S., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1993d. A longitudinal twin study of personality and major depression in women. Arch Gen Psychiatry 50, 853-862.
154. Kendler, K.S., Silberg, J.L., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1992d. Genetic and environmental factors in the aetiology of menstrual, premenstrual and neurotic symptoms: a population-based twin study. Psychol Med 22, 85-100.
155. Kendler, K.S., Walters, E.E., Neale, M.C., Kessler, R.C., Heath, A.C., Eaves, L.J., 1995b. The structure of the genetic and environmental risk factors for six major psychiatric disorders in women. Phobia, generalized anxiety disorder, panic disorder, bulimia, major depression, and alcoholism. Arch Gen Psychiatry 52, 374-383.
156. Kessler, R.C., 1995. Epidemiology of psychiatric comorbidity. In: Tsuang, M.T., Tohan, M., Zahner, G.E.P. (Eds.), Textbook in Psychiatric Epidemiology. John Wiley & Sons Inc., New York, NY, pp. 179-197.
157. Kessler, R.C., Kendler, K.S., Heath, A., Neale, M.C., Eaves, L.J., 1992. Social support, depressed mood, and adjustment to stress: a genetic epidemiologic investigation. J Pers Soc Psychol 62, 257-272.
158. Kessler, R.C., Kendler, K.S., Heath, A., Neale, M.C., Eaves, L.J., 1994. Perceived support and adjustment to stress in a general population sample of female twins. Psychol Med 24, 317-334.
159. Kessler, R.C., Magee, W.J., 1993. Childhood adversities and adult depression: basic patterns of association in a US national survey. Psychol Med 23, 679-690.
160. Kessler, R.C., McLeod, J.D., 1985. Social support and psychological distress in community samples. In: Cohen, S., Syme, L. (Eds.), Social Support and Health. Academic Press, Orlando, FL.
161. Kessler, R.C., Zhao, S., Blazer, D.G., Swartz, M., 1997. Prevalence, correlates, and course of minor depression and major depression in the National Comorbidity Survey. J Affect Disord 45, 19-30.
162. Kouri, E.M., Halbreich, U., 1997. State and trait serotonergic abnormalities in women with dysphoric premenstrual syndromes. Psychopharmacol Bull 33, 767-770.
163. Landen, M., Eriksson, E., 2003. How does premenstrual dysphoric disorder relate to depression and anxiety disorders? Depress Anxiety 17, 122-129.
164. Le Melledo, J.M., Merani, S., Koszycki, D., Bellavance, F., Palmour, R., Gutkowska, J., Steinberg, S., Bichet, D.G., Bradwejn, J., 1999. Sensitivity to CCK-4 in women with and without premenstrual dysphoric disorder (PMDD) during their follicular and luteal phases. Neuropsychopharmacology 20, 81-91.
165. Le Melledo, J.M., Van Driel, M., Coupland, N.J., Lott, P., Jhangri, G.S., 2000. Response to flumazenil in women with premenstrual dysphoric disorder. American Journal of Psychiatry 157, 821-823.
166. Leather, A.T., Studd, J.W., Watson, N.R., Holland, E.F., 1999. The treatment of severe premenstrual syndrome with goserelin with and without 'add-back' estrogen therapy: a placebo-controlled study. Gynecol Endocrinol 13, 48-55.
167. Lewis, L.L., Greenblatt, E.M., Rittenhouse, C.A., Veldhuis, J.D., Jaffe, R.B., 1995. Pulsatile release patterns of luteinizing hormone and progeserone in relation to symptom onset in women with premenstrual syndrome. Fertil Steril 64, 288-292.
168. Lin, N., Dean, A., Ensel, W., 1986. Social support, life events, and depression. Academic Press, New York.
169. Ling, F.W., Brown, C.S., 1990. Clinical phenomenology of PMS: implications for the physician in a nonpsychiatric specialty area, Fourth National Institute of Mental Health International Research Conference on the Classification and Treatment of Mental Disorders in General Medical Settings. Bethesda, MD, June 1990.
170. Lloyd, K.G., Zivkovic, B., Scatton, B., Morselli, P.L., Bartholini, G., 1989. The GABAergic hypothesis of depression. Prog Neuropsychopharmacol Biol Psychiatry 13, 341-351.
171. Luggin, R., Bernsted, L., Petersson, B., Jacobsen, A.T., 1984. Acute psychiatric admission related to the menstrual cycle. Acta Psychiat Scand 69, 461-465.
172. Luine, V.N., 1985. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 89, 484-490.
173. Lundberg, P.O., 1997. Catamenial epilepsy: a review. Cephalagia Suppl 20, 42-45.
174. Maskall, D.D., Lam, R.W., Misri, S., Carter, D., Kuan, A.J., Yatham, L.N., Zis, A.P., 1997. Seasonality of symptoms in women with late luteal phase dysphoric disorder. American Journal of Psychiatry 154, 1436-1441.
175. Matsumoto, A., Arai, Y., Osanai, M., 1985. Estrogen stimulates neuronal plasticity in the deafferented hypothalamic arcuate nucleus in aged female rats. Neurosci Res 2, 412-418.
176. McEwen, B.S., Alves, S.E., Bulloch, K., 1997. Ovarian steroids and the brain: Implications for cognition and aging. Neurology 48, Suppl 7, S8-S15.
177. McEwen, B.S., Alves, S.E., Bulloch, K., Weiland, N.G., 1998. Clinically-relevant basic sciences studies of gender differences and sex hormones effects. Psychopharmacol Bull 34, 251-259.
178. McEwen, B.S., Woolley, C.S., 1994. Estradiol and progesterone regulate neuronal structure and synaptic connectivity in adult as well as developing brain. Exp Gerontol 29, 431-436.
179. McFarland, R.A., 1957. The role of human factors in accidental trauma. Am J Med Sci 234, 1-26.
180. McGuffin, P., Katz, R., Aldrich, J., Bebbington, P., 1988a. The Camberwell Collaborative Depression Study, II: investigation of family members. Br J Psychiatry 152, 766-774.
181. McGuffin, P., Katz, R., Bebbington, P., 1988b. The Camberwell collaborative depression study, III: depression and adversity in the relatives of depressed probands. Br J Psychiatry 152, 775-782.
182. Meltzer, H.Y., Lowry, M.T., 1987. The serotonin hypothesis of depression. Raven Press, New York.
183. Merikangas, K.R., Foeldenyl, M., Angst, J., 1993. The Zurich Study. XIX. Patterns of menstrual disturbances in the community: results of the Zurich Cohort Study. Eur Arch Psychiatry Clin Neurosci 243, 23-32.
184. Metz, A., Stump, K., Cowen, P.J., Elliott, J.M., Gelder, M.G., Grahame-Smith, D.G., 1983. Changes in platelet alpha 2-adrenoceptor binding post partum: possible relation to maternity blues. Lancet 1, 495-498.
185. Miner, C., Brown, E., McCray, S., Gonzales, J., Wohlreich, M., 2002. Weekly luteal-phase dosing with enteric-coated fluoxetine 90 mg in premenstrual dysphoric disorder: a randomized, double-blind, placebo-controlled clinical trial. Clin Ther 24, 417-433.
186. Mitwally, M.F., Kahn, L.S., Halbreich, U., 2002. Pharmacotherapy of premenstrual syndromes and pre-menstrual dysphoric disorder: current practices. Expert Opinion on Pharmacotherapy 3, 1577-1590.
187. Morrell, M.J., 1999. Epilepsy in women: the science of why it is special. Neurology 53, S42-S48.
188. Oelkers, W., Berger, V., Bolik, A., Bahr, V., Hazard, B., Beier, S., Elger, W., Heithecker, A., 1991. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women. J Clin Endocrinol Metab 73, 837-842.
189. Oelkers, W., Foidart, J.M., Dombrovicz, N., Welter, A., Heithecker, R., 1995. Effects of a new oral contraceptive containing an antimineralocorticoid progestogen, drospirenone, on the renin-aldosterone system, body weight, blood pressure, glucose tolerance, and lipid metabolism. J Clin Endocrinol Metab 80, 1816-1821.
190. Oelkers, W.K., 1996. Effects of estrogens and progestogens on the renin-aldosterone system and blood pressure. Steroids 61, 166-171.
191. Ohkura, T., Teshima, Y., Isse, K., 1994. Estrogen increases cerebral and cerebellar blood flow in post-menopausal women. Menopause 2, 13-18.
192. Olson, B.R., Forman, M.R., Lanza, E., McAdam, P.A., Beecher, G., Kimzey, L.M., Campbell, W.S., Raymond, E.G., Brentzel, S.L., Guttsches-Ebeling, B., 1996. Relation between sodium balance and menstrual cycle symptoms in normal women. Ann Intern Med 125, 564-567.
193. Ostensen, M., Rugelsjoen, A., Wigers, S.H., 1997. The effect of reproductive events and alterations of sex hormone levels on the symptoms of fibromyalgia. Scand J Rheumatol 26, 355-360.
194. Parker, G., 1979. Parental characteristics in relation to depressive disorders. Br J Psychiatry 134, 138-147.
195. Parry, B.L., Rosenthal, N.E., Tamarkin, L., Wehr, T.A., 1987. Treatment of a patient with seasonal pre-menstrual syndrome. American Journal of Psychiatry 144, 762-766.
196. Parsey, K.S., Pong, A., 2000. An open-label, multicenter study to evaluate Yasmin, a low-dose combination oral contraceptive containing drospirenone, a new progestogen. Contraception 61, 105-111.
197. Paul, S.M., Purdy, R.H., 1992. Neuroactive steroids. Faseb J 6, 2311-2322.
198. Pearlstein, T.B., Frank, E., Rivera-Tovar, A., Thoft, J.S., Jacobs, E., Mieczkowski, T.A., 1990. Prevalence of axis I and axis II disorders in women with late luteal phase dysphoric disorder. J Affect Disord 20, 129-134.
199. Petty, F., Kramer, G.L., Fulton, M., Moeller, F.G., Rush, A.J., 1993. Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacology 9, 125-132.
200. Piletz, J.E., Halaris, A., Saran, A., Marler, M.R., 1991. Desipramine lowers tritiated para-aminoclonidine binding in platelets of depressed patients. Arch Gen Psychiatry 48, 813-820.
201. Plomin, R., Lichtenstein, P., Pedersen, N., McClearn, G.E., Nesselrode, J.R., 1990. Genetic influences on life events during the last half of the life span. Psychol Aging 5, 25-30.
202. Poulton, R.G., Andrews, G., 1992. Personality as a cause of adverse life events. Acta Psychiatr Scand 85, 35-38.
203. Praschak-Rieder, N., Willeit, M., Neumeister, A., Hilger, E., Stastny, J., Thierry, N., Lenzinger, E., Kasper, S., 2001. Prevalence of premenstrual dysphoric disorder in female patients with seasonal affective disorder. J Affect Disord 63, 239-242.
204. Price, R.A., Kidd, K.K., Weissman, M.M., 1987. Early onset (under age 30 years) and panic disorder as markers etiologic homogeneity in major depression. Arch Gen Psychiatry 44, 434-440.
205. Ramcharan, S., Love, E.J., Fick, G.H., Goldfien, A., 1992. The epidemiology of premenstrual symptoms in a population-based sample of 2650 urban women: Attributable risk and risk factors. J Clin Epidemiol 45, 377-392.
206. Rapkin, A.J., Edelmuth, E., Chang, L.C., Reading, A.E., McGuire, M.T., Su, T.P., 1987. Whole-blood serotonin in premenstrual syndrome. Obstet Gynecol 70, 533-537.
207. Rapkin, A.J., Morgan, M., Goldman, L., Brann, D.W., Simone, D., Mahesh, V.B., 1997. Progesterone metabolite allopregnanolone in women with premenstrual syndrome. Obstet & Gynecol 90, 709-714.
208. Rapkin, A.J., Shoupe, D., Reading, A., Daneshgar, K.K., Goldman, L., Bohn, Y., Brann, D.W., Mahesh, V.B., 1996. Decreased central opioid activity in premenstrual syndrome: luteinizing hormone response to naloxone. Journal of the Society For Gynecologic Investigation 3, 93-98.
209. Redei, E., Freeman, E.D., 1995. Daily plasma estradiol and progesterone levels over the menstrual cycle and their relation to premenstrual symptoms. Psychoneuroendocrinology 20, 259-267.
210. Reid, R.L., Yen, S.S., 1981. Premenstrual syndrome. Am J Obstet & Gynecol 139, 85-104.
211. Rivera-Tovar, A.D., Frank, E., 1990. Late luteal phase dysphoric disorder in young women. Am J Psychiatry 147, 1634-1636.
212. Roca, C.A., Schmidt, P.J., Rubinow, D.R., 1999. A follow-up study of premenstrual syndrome. Journal of Clinical Psychiatry 60, 763-766.
213. Rogers, M.P., White, K., Warshaw, M.G., Yonkers, K.A., Rodriguez-Villa, F., Chang, G., Keller, M.B., 1994. Prevalence of medical illness in patients with anxiety disorders. International Journal of Psychiatry in Medicine 24, 83-96.
214. Rojansky, N., Halbreich, U., Zander, K., Barkai, A., Goldstein, S., 1991. Imipramine receptor binding and serotonin uptake in platelets of women with premenstrual changes. Gynecol Obstet Invest 31, 146-152.
215. Roy, A., 1978. Vulnerability factors and depression in women. Psychiatry 133, 106-110.
216. Roy, A., 1987. Five risk factors for depression. Br J Psychiatry 150, 536-541.
217. Roy-Byrne, P.P., Rubinow, D.R., Hoban, M.C., Grover, G.N., Blank, D., 1987. TSH and prolactin responses to TRH in patients with premenstrual syndrome. Am J Psychiatry 144, 480.
218. Rubinow, D.R., Hoban, M.C., Grover, G.N., Galloway, D.S., Roy-Byrne, P., Andersen, R., Merriam, G.R., 1988. Changes in plasma hormones across the menstrual cycle in patients with menstrually related mood disorder and in control subjects. Am J Obstet Gynecol 158, 5-11.
219. Sandberg, D., Endicott, J., Harrison, W., Nee, J., Gorman, J., 1993. Sodium lactate infusion in late luteal phase dysphoric disorder. Psychiatr Res 46, 79-88.
220. Schechter, D., 1999. Estrogen, progesterone, and mood. J Gend Specif Med 2, 29-36.
221. Schmidt, P.J., Grover, G.N., Rubinow, D.R., 1993. Alprazolam in the treatment of premenstrual syndrome. A double-blind, placebo-controlled trial. Arch Gen Psychiatry 50, 467-473.
222. Schmidt, P.J., Nieman, L.K., Danaceau, M.A., Adams, L.F., Rubinow, D.R., 1998. Differential behavioral effects of gonadal steroids in women with and in those without premenstrual syndrome. N Eng J Med 338, 209-216.
223. Schmidt, P.J., Nieman, L.K., Grover, G.N., Muller, K.L., Merriam, G.R., Rubinow, D.R., 1991. Lack of effect of induced menses on symptoms in women with premenstrual syndrome. N Eng J Med 324, 1174-1179.
224. Schmidt, P.J., Purdy, R.H., Moore, P.H. Jr., Paul, S.M., Rubinow, D.R., 1994. Circulating levels of anxiolytic steroids in the luteal phase in women with premenstrual syndrome and in control subjects. J Clin Endocrinol Metab 79, 1256-1260.
225. Schuckit, M.A., Daly, V., Herman, G., Hineman, S., 1975. Perimenstrual symptoms and depression in a university population. Diseases of the Nervous System 36, 560-617.
226. Seippel, L., Backstrom, T., 1998. Luteal-phase estradiol relates to symptom severity in patients with premenstrual syndrome. Journal of Clinical Endocrinology & Metabolism 83, 1988-1992.
227. Severino, S.K., Hurt, S.W., Shindledecker, R.D., 1989. Late luteal phase dysphoric disorder: spectral analysis of cyclic symptoms. Am J Psychiatry 146, 1155-1160.
228. Silberstein, S.D., 1999. Menstrual migraine. J Womens Health Gend Based Med 8, 919-931.
229. Simpkins, J.W., Singh, M., Bishop, J., 1994. The potential role for estrogen replacement therapy in the treatment of the cognitive decline and neurodegeneration associated with Alzheimer's disease. Neurobiol Aging 15, S195-S197.
230. Singh, M., Meyer, E.M., Simpkins, J.W., 1994. Ovarian steroid deprivation results in a reversible learning impairment and compromised cholinergic function in Sprague-Dawley rats. Brain Res 644, 305-312.
231. Singh, M., Meyer, E.M., Simpkins, J.W., 1995. The effect of ovariectomy and oestradiol replacement on brain-derived neurotrophic factor messenger ribonucleic acid expression in cortical and hippocampal brain regions of female Sprague-Dawley rats. Endocrinology 136, 2320-2324.
232. Smith, S., 1993. Treatment for the physical symptoms of premenstrual syndrome. In: Smith, S., Schiff, I. (Eds.), Modern management of premenstrual syndrome. W. W. Norton & Co., New York, pp. 112-119.
233. Steege, J.F., Stout, A.L., Knight, D.L., Nemeroff, C.B., 1992. Reduced platelet tritium-labeled imipramine binding sites in women with premenstrual syndrome. Am J Obstet Gynecol 167, 168-172.
234. Steinberg, S., Annable, L., Young, S.N., Liyanage, N., 1999. A placebo-controlled study of the effects of L-tryptophan in patients with premenstrual dysphoria. Adv Exp Med Biol 467, 85-88.
235. Steiner, M., Haskett, R.F., Carroll, B.J., 1980. Premenstrual tension syndrome: the development of research diagnostic criteria and new rating scales. Acta Psychiatr Scand 62, 177-190.
236. Stewart, D.E., Boydell, K.M., 1993. Psychologic distress during menopause: associations across the reproductive life cycle. International Journal of Psychiatry in Medicine 23, 157-162.
237. Stout, A.L., Steege, J.F., Blazer, D.G., George, L.K., 1986. Comparison of lifetime diagnosis in premenstrual syndrome: clinic and community samples. Journal of Nervous and Mental Disorders 174, 517-521.
238. Studd, J.W.W., Smith, R.N.J., 1990. Estrogens and Depression in Women. Menopause. The Journal of the North American Menopause Society 1, 33-37.
239. Su, T.P., Schmidt, P.J., Danaceau, M., Murphy, D.L., Rubinow, D.R., 1997. Effect of menstrual cycle phase on neuroendocrine and behavioral responses to the serotonin agonist m-chlorophenylpiperazine in women with premenstrual syndrome and controls. Journal of Clinical Endocrinology & Metabolism 82, 1220-1228.
240. Sugawara, M., Toda, M.A., Shima, S., Mukai, T., Sakakura, K., Kitamura, T., 1997. Premenstrual mood changes and maternal mental health in pregnancy and the postpartum period. Journal of Clinical Psychology 53, 225-232.
241. Sundstrom, I., Andersson, A., Nyberg, S., Ashbrook, D., Purdy, R.H., Backstrom, T., 1998. Patients with premenstrual syndrome have a different sensitivity to a neuroactive steroid during the menstrual cycle compared to control subjects. Neuroendocrinology 67, 126-138.
242. Sundstrom, I., Ashbrook, D., Backstrom, T., 1997a. Reduced benzodiazepine sensitivity in patients with premenstrual syndrome: a pilot study. Psychoneuroendocrinology 22, 25-38.
243. Sundstrom, I., Backstrom, T., 1998a. Citalopram increases pregnanolone sensitivity in patients with premenstrual syndrome: an open trial. Psychoneuroendocrinology 23, 73-88.
244. Sundstrom, I., Backstrom, T., 1998b. Patients with premenstrual syndrome have decreased saccadic eye velocity compared to control subjects. Biological Psychiatry 44, 755-764.
245. Sundstrom, I., Nyberg, S., Backstrom, T., 1997b. Patients with premenstrual syndrome have reduced sensitivity to midazolam compared to control subjects. Neuropsychopharmacology 17, 370-381.
246. Sundstrom, I., Nyberg, S., Bixo, M., Hammarback, S., Backstrom, T., 1999. Treatment of premenstrual syndrome with gonadotropin-releasing hormone agonist in a low dose regimen. Acta Obstet Gynecol Scand 78, 891-899.
247. Surtees, P.G., Miller, P.M., Ingham, J.G., Kreitman, N.B., Rennie, D., Sashidharan, S.P., 1986. Life events and the onset of affective disorder: a longitudinal general population study. J Affect Disord 10, 37-50.
248. Taylor, D.L., Mathew, R.J., Ho, B.T., Weinman, M.L., 1984. Serotonin levels and platelet uptake during premenstrual tension. Neuropsychobiology 12, 16-18.
249. Tennant, C., 1988. Parental loss in childhood: its effect in adult life. Arch Gen Psychiatry 45, 1045-1050.
250. Thoits, P.A., 1983. Dimensions of life events that influence psychological distress: an evaluation and synthesis of the literature. In: Kaplan, H.B. (Ed.), Psychological Stress: Trends in Theory and Research. Academic Press, New York, NY.
251. Tillmann, W.A., Hobbs, G.E., 1949. The accident-prone automobile driver: a study of the psychiatric and social background. Am J Psychiatry 106, 321-331.
252. Tsuang, M.T., Boor, M., Fleming, J.A., 1985. Psychiatric aspects of traffic accidents. Am J Psychiatry 142, 538-546.
253. Tsuang, M.T., Faranone, S.V., 1990. The Genetics of Mood Disorders. The Johns Hopkins University Press, Baltimore, MD.
254. Tulenheimo, A., Laatikainen, T., Salminen, K., 1987. Plasma beta-endorphin immunoreactivity in premenstrual tension. Br J Obstet Gynaecol 94, 26-29.
255. Van den Akker, O.B., Stein, G.S., Neale, M.C., Murray, R.M., 1987. Genetic and environmental variation in menstrual cycle: histories of two British twin samples. Acta Genet Med Gemellol (Roma) 36, 541-548.
256. Veldhuis, J.D., Christiansen, E., Evans, W.S., Kolp, L.A., Rogol, A.D., Johnson, M.L., 1988. Physiological profiles of episodic progesterone release during the midluteal phase of the human menstrual cycle: analysis of circadian and ultradian rhythms, discrete pulse properties, and correlations with simultaneous luteinizing hormone release. J Clin Endocrinol Metab 66, 414-421.
257. Wang, M., Seippel, L., Purdy, R.H., Backstrom, T., 1996. Relationship between symptom severity and steroid variation in women with premenstrual syndrome: study on serum pregnenolone, pregnenolone sulfate, 5 alpha-pregnane-3,20-dione and 3 alpha-hydroxy-5 alpha-pregnan-20-one. J Clin Endocrinol Metab 81, 1076-1082.
258. Warner, P., Bancroft, J., Dixson, A., Hampson, M., 1991. The relationship between perimenstrual depressive mood and depressive illness. J Affect Disord 23, 9-23.
259. Weissman, M.M., Bland, R.C., Canino, G.J., Faravelli, C., Greenwald, S., Hwu, H.G., Joyce, P.R., Karam, E.G., Lee, C.K., Lellouch, J., et al. 1996. Cross-national epidemiology of major depression and bipolar disorder. JAMA 276, 293-299.
260. Weissman, M.M., Klerman, G.L., 1977. Sex differences and the epidemiology of depression. Arch Gen Psychiatry 34, 98-111.
261. Weissman, M.M., Olfson, M., 1995. Depression in women: implications for health care research. Science 269, 799-801.
262. Wentzel, J.N., Reich, T., McClure, J.M., Wald, I., 1975. Premenstrual affective syndrome and affective disorder. Br J Psychiatry 127, 219-221.
263. West, C.P., Lumsden, M.A., Baird, D.T., 1989. Modification of symptoms of the premenstrual syndrome during ovarian suppression with goserelin (Zoladex) depot - Potential for research and clinical investigation. J Psychosom Obstet Gynecol 10, 79-88.
264. Whybrow, P.C., Akiskal, H.S., McKinney, W.T.J., 1984. Toward a psychobiological integration: affective illness as a final common path to adaptive failure, mood disorders: Toward a new psychobiology. Plenum, New York.
265. Wittchen, H.U., Becker, E., Lieb, R., Krause, P., 2002. Prevalence, incidence and stability of premenstrual dysphoric disorder in the community. Psychological Medicine January 32, 119-132.
266. Wolley, C.S., McEwen, B.S., 1992. Estradiol mediates fluctuation in hippocampal synapse density during the estrous cycle in the adult rat. J Neurosci 12, 2549-2554.
267. Wyatt, G.E., Powell, G.J., 1988. Identifying the lasting effects of child sexual abuse: an overview. In: Wyatt, G.E., Powell, G.J. (Eds.), Lasting effects of child sexual abuse. Sage Publications, Newberry Park, California.
268. Yonkers, K.A., 1997a. Anxiety symptoms and anxiety disorders: how are they related to premenstrual disorders? Journal of Clinical Psychiatry 58 (62-67), 68-69 (discussion).
269. Yonkers, K.A., 1997b. The association between premenstrual dysphoric disorder and other mood disorders. J Clin Psychiatry 58, 19-25.
270. Zorgdrager, A., De Keyser, J., 1998. Premenstrual exacerbations of multiple sclerosis. Journal of Neurology. Neurosurgery & Psychiatry 65, 279-280.